Adaptive immune response during hepatitis C virus infection

Hepatitis C virus(HCV)infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma.HCV is a hepatotropic non-cytopathic virus able to persist in a great percentage of infected hosts due to its ability to escape from the immune control.L...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG Vol. 20; no. 13; pp. 3418 - 3430
Main Author: Larrubia, Juan Ramón
Format: Journal Article
Language:English
Published: United States Baishideng Publishing Group Co., Limited 07-04-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Hepatitis C virus(HCV)infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma.HCV is a hepatotropic non-cytopathic virus able to persist in a great percentage of infected hosts due to its ability to escape from the immune control.Liver damage and disease progression during HCV infection are driven by both viral and host factors.Specifically,adaptive immune response carries out an essential task in controllingnon-cytopathic viruses because of its ability to recognize infected cells and to destroy them by cytopathic mechanisms and to eliminate the virus by non-cytolytic machinery.HCV is able to impair this response by several means such as developing escape mutations in neutralizing antibodies and in T cell receptor viral epitope recognition sites and inducing HCV-specific cytotoxic T cell anergy and deletion.To impair HCV-specific T cell reactivity,HCV affects effector T cell regulation by modulating T helper and Treg response and by impairing the balance between positive and negative co-stimulatory molecules and between pro-and antiapoptotic proteins.In this review,the role of adaptive immune response in controlling HCV infection and the HCV mechanisms to evade this response are reviewed.
AbstractList Hepatitis C virus (HCV) infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV is a hepatotropic non-cytopathic virus able to persist in a great percentage of infected hosts due to its ability to escape from the immune control. Liver damage and disease progression during HCV infection are driven by both viral and host factors. Specifically, adaptive immune response carries out an essential task in controlling non-cytopathic viruses because of its ability to recognize infected cells and to destroy them by cytopathic mechanisms and to eliminate the virus by non-cytolytic machinery. HCV is able to impair this response by several means such as developing escape mutations in neutralizing antibodies and in T cell receptor viral epitope recognition sites and inducing HCV-specific cytotoxic T cell anergy and deletion. To impair HCV-specific T cell reactivity, HCV affects effector T cell regulation by modulating T helper and Treg response and by impairing the balance between positive and negative co-stimulatory molecules and between pro- and anti-apoptotic proteins. In this review, the role of adaptive immune response in controlling HCV infection and the HCV mechanisms to evade this response are reviewed.
Hepatitis C virus(HCV)infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma.HCV is a hepatotropic non-cytopathic virus able to persist in a great percentage of infected hosts due to its ability to escape from the immune control.Liver damage and disease progression during HCV infection are driven by both viral and host factors.Specifically,adaptive immune response carries out an essential task in controllingnon-cytopathic viruses because of its ability to recognize infected cells and to destroy them by cytopathic mechanisms and to eliminate the virus by non-cytolytic machinery.HCV is able to impair this response by several means such as developing escape mutations in neutralizing antibodies and in T cell receptor viral epitope recognition sites and inducing HCV-specific cytotoxic T cell anergy and deletion.To impair HCV-specific T cell reactivity,HCV affects effector T cell regulation by modulating T helper and Treg response and by impairing the balance between positive and negative co-stimulatory molecules and between pro-and antiapoptotic proteins.In this review,the role of adaptive immune response in controlling HCV infection and the HCV mechanisms to evade this response are reviewed.
Author Juan Ramón Larrubia Elia Moreno-Cubero Megha Uttam Lokhande Silvia García-Garzón Alicia Lázaro Joaquín Miquel Cristian Perna Eduardo Sanz-de-Villalobos
AuthorAffiliation Translational Hepatology Unit,Guadalajara University Hospital,University of Alcalá,E-19002 Guadalajara,Spain Department of Medicine and Medical Specialities,School of Medicine,University of Alcalá,E-28801 Alcalá de Henares,Spain
Author_xml – sequence: 1
  givenname: Juan Ramón
  surname: Larrubia
  fullname: Larrubia, Juan Ramón
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24707125$$D View this record in MEDLINE/PubMed
BookMark eNpVkN1KAzEQhYMo2lbvvZJ9ga2TSbLJIghS_IOCN3od0t2kTWmz62Zb8e1NaS06MMwMM-cMfENyGppgCbmmMGaSq9uv5Xy8RRh7ysaMU3VCBoi0zFFxOCUDCiDzkqG8IMMYlwDImMBzcoFcgqQoBuTuoTZt77c28-v1Jtiss7FtQrRZvel8mGcL25re9z5mk2zru03MfHC26n0TLsmZM6torw51RD6eHt8nL_n07fl18jDNK86hzx04KZlhiEXhKlXzmeXOYVrysgKcucqAK1RNpRRpEhyZYAWwmmFBleFsRO73vu1mtrZ1ZUPfmZVuO7823bdujNf_N8Ev9LzZalZKLqBMBrA3qLomxs66o5aC3oHUCaROIHUCqXcgk-Tm78-j4JdcOmAHz0UT5p8J1fGmBLWLUgBXvBSYkqZOCWQ_3kCCAw
CitedBy_id crossref_primary_10_3390_cells7110196
crossref_primary_10_3389_fimmu_2022_886646
crossref_primary_10_1371_journal_pone_0209481
crossref_primary_10_1128_JVI_01443_17
crossref_primary_10_1099_jgv_0_000447
crossref_primary_10_1016_j_clim_2020_108482
crossref_primary_10_1016_j_ijid_2016_02_025
crossref_primary_10_3390_cells10030538
crossref_primary_10_3390_v12010101
crossref_primary_10_3389_fimmu_2018_02014
crossref_primary_10_3748_wjg_v22_i4_1382
crossref_primary_10_1016_j_jval_2022_05_010
crossref_primary_10_1371_journal_ppat_1004788
crossref_primary_10_1155_2018_4639805
crossref_primary_10_1080_07391102_2019_1696705
crossref_primary_10_3390_ijms18081626
crossref_primary_10_1186_s12979_023_00387_z
crossref_primary_10_4049_jimmunol_1400337
crossref_primary_10_1089_jir_2021_0106
crossref_primary_10_1016_j_aquaculture_2024_740570
crossref_primary_10_1016_j_dld_2015_06_014
crossref_primary_10_2174_1573401316999201009152726
crossref_primary_10_1016_j_virusres_2015_12_003
crossref_primary_10_18632_aging_103395
crossref_primary_10_12688_f1000research_7354_1
crossref_primary_10_4103_ejim_ejim_14_19
crossref_primary_10_4254_wjh_v7_i22_2369
crossref_primary_10_3748_wjg_v24_i17_1825
crossref_primary_10_3748_wjg_v22_i28_6469
crossref_primary_10_1016_j_biopha_2018_06_095
crossref_primary_10_1080_14787210_2018_1505502
crossref_primary_10_3390_cells7100165
crossref_primary_10_1016_j_idcr_2019_e00534
crossref_primary_10_4161_hv_36134
crossref_primary_10_4236_ojgas_2022_124011
crossref_primary_10_1016_j_arr_2023_102068
crossref_primary_10_1517_14712598_2015_1106475
crossref_primary_10_1111_odi_13069
crossref_primary_10_1097_MD_0000000000019013
crossref_primary_10_1586_14760584_2016_1123098
crossref_primary_10_3390_biom11111664
crossref_primary_10_4254_wjh_v12_i10_754
crossref_primary_10_4254_wjh_v15_i5_649
crossref_primary_10_1016_j_jpeds_2015_11_055
crossref_primary_10_1080_02656736_2017_1387938
crossref_primary_10_3748_wjg_v21_i12_3480
ContentType Journal Article
Copyright 2014 Baishideng Publishing Group Co., Limited. All rights reserved. 2014
Copyright_xml – notice: 2014 Baishideng Publishing Group Co., Limited. All rights reserved. 2014
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.3748/wjg.v20.i13.3418
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Adaptive immune response during hepatitis C virus infection
EISSN 2219-2840
EndPage 3430
ExternalDocumentID 10_3748_wjg_v20_i13_3418
24707125
90888889504849524951484852
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c440t-f0f773a32266fc8d4be4ff2c4449c02bfca0f68d17752bf542353603d32618a43
IEDL.DBID RPM
ISSN 1007-9327
IngestDate Tue Sep 17 20:55:14 EDT 2024
Thu Nov 21 20:42:20 EST 2024
Thu May 23 23:21:38 EDT 2024
Wed Feb 14 10:28:37 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 13
Keywords Hepatitis C virus-specific T helper cells
Hepatitis C virus-specific cytotoxic T cells
Hepatitis C virus escape mutations
Anergy
T regs
Adaptive immune response
Hepatitis C
Chemotaxis
Apoptosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c440t-f0f773a32266fc8d4be4ff2c4449c02bfca0f68d17752bf542353603d32618a43
Notes Juan Ramón Larrubia;Elia Moreno-Cubero;Megha Uttam Lokhande;Silvia García-Garzón;Alicia Lázaro;Joaquín Miquel;Cristian Perna;Eduardo Sanz-de-Villalobos;Translational Hepatology Unit,Guadalajara University Hospital,University of Alcalá,E-19002 Guadalajara,Spain;Department of Medicine and Medical Specialities,School of Medicine,University of Alcalá,E-28801 Alcalá de Henares,Spain
Telephone: +34-949-909200 Fax: +34-949-209256
Correspondence to: Juan Ramón Larrubia, MD, MSc, PhD, Translational Hepatology Unit, Guadalajara University Hospital, University of Alcalá, Donante de Sangre st, E-19002 Guadalajara, Spain. juan.larrubia@uah.es
Author contributions: Larrubia JR contributed towards the conception and design of the review; Larrubia JR, Moreno-Cubero E and Lokhande MU co-wrote and Larrubia JR revised the manuscript; García-Garzón S, Lázaro A, Miquel J, Perna C and Sanz-de-Villalobos E contributed equally to the supportive work and supervision.
OpenAccessLink https://doi.org/10.3748/wjg.v20.i13.3418
PMID 24707125
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3974509
crossref_primary_10_3748_wjg_v20_i13_3418
pubmed_primary_24707125
chongqing_primary_90888889504849524951484852
PublicationCentury 2000
PublicationDate 2014-04-07
PublicationDateYYYYMMDD 2014-04-07
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-07
  day: 07
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationYear 2014
Publisher Baishideng Publishing Group Co., Limited
Publisher_xml – name: Baishideng Publishing Group Co., Limited
References 18508291 - Hepatology. 2008 Jul;48(1):299-307
12949239 - J Leukoc Biol. 2003 Sep;74(3):360-9
22362353 - Nat Rev Immunol. 2012 Mar;12(3):201-13
19380744 - Proc Natl Acad Sci U S A. 2009 May 5;106(18):7537-41
23301543 - J Viral Hepat. 2013 Feb;20(2):85-94
12946990 - Blood. 2003 Dec 15;102(13):4487-92
14768047 - Eur J Immunol. 2004 Feb;34(2):427-37
20686664 - PLoS Pathog. 2010;6(7):e1001018
17182670 - J Virol. 2007 Mar;81(6):2545-53
17326153 - Hepatology. 2007 Mar;45(3):588-601
11009080 - Eur J Immunol. 2000 Sep;30(9):2479-87
16496339 - Hepatology. 2006 Mar;43(3):563-72
19527080 - Rev Esp Enferm Dig. 2009 May;101(5):343-51
9410918 - J Clin Invest. 1997 Nov 1;100(9):2376-85
23217614 - Virology. 2013 Jan 5;435(1):37-45
11714747 - J Exp Med. 2001 Nov 19;194(10):1395-406
18337576 - J Virol. 2008 May;82(10):5109-14
17050612 - J Virol. 2007 Jan;81(1):374-83
15057302 - J Clin Invest. 2004 Apr;113(7):963-72
19084927 - World J Gastroenterol. 2008 Dec 21;14(47):7149-59
15939791 - J Exp Med. 2005 Jun 6;201(11):1753-9
18184704 - J Virol. 2008 Mar;82(6):3147-53
18039107 - Annu Rev Pathol. 2006;1:23-61
10500077 - Gastroenterology. 1999 Oct;117(4):933-41
15486925 - Hepatology. 2004 Nov;40(5):1062-71
16799989 - Hepatology. 2006 Jul;44(1):126-39
15655045 - J Viral Hepat. 2005 Jan;12(1):27-37
23569333 - World J Gastroenterol. 2013 Mar 28;19(12):1877-89
10570316 - J Immunol. 1999 Dec 1;163(11):6236-43
17258733 - Gastroenterology. 2007 Feb;132(2):654-66
19139562 - J Clin Invest. 2009 Feb;119(2):376-86
17376924 - J Virol. 2007 Jun;81(11):5882-92
9882313 - J Virol. 1999 Feb;73(2):1118-26
15919940 - J Virol. 2005 Jun;79(12):7860-7
22049091 - J Gen Virol. 2012 Jan;93(Pt 1):1-19
17304234 - Nat Immunol. 2007 Mar;8(3):239-45
18198374 - J Gen Virol. 2008 Feb;89(Pt 2):432-43
17133491 - Hepatology. 2006 Dec;44(6):1607-16
16413618 - Antiviral Res. 2006 Mar;69(3):129-41
20875418 - Gastroenterology. 2011 Feb;140(2):686-696.e1
10622558 - J Hepatol. 1999;31 Suppl 1:39-42
10972499 - Curr Opin Microbiol. 2000 Aug;3(4):387-92
20100932 - J Immunol. 2010 Mar 1;184(5):2410-22
15939788 - J Exp Med. 2005 Jun 6;201(11):1725-31
8986822 - Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15394-9
10798608 - J Clin Immunol. 2000 Jan;20(1):54-61
12591185 - J Hepatol. 2003;38 Suppl 1:S38-53
17560677 - J Hepatol. 2007 Nov;47(5):632-41
18549878 - Gastroenterology. 2008 Jun;134(7):1927-37, 1937.e1-2
16571809 - J Virol. 2006 Apr;80(8):3923-34
15939790 - J Exp Med. 2005 Jun 6;201(11):1741-52
19303013 - Gastroenterology. 2009 Jun;136(7):2377-86
17567698 - J Virol. 2007 Sep;81(17):9249-58
14987324 - Aliment Pharmacol Ther. 2004 Mar 1;19(5):551-62
16478885 - Blood. 2006 Jun 1;107(11):4424-32
17559151 - Hepatology. 2007 Aug;46(2):339-49
16717132 - Blood. 2006 Jun 1;107(11):4570-1
15919939 - J Virol. 2005 Jun;79(12):7852-9
16956940 - J Virol. 2006 Nov;80(22):11398-403
21059929 - Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20453-8
12425561 - Am J Gastroenterol. 2002 Nov;97(11):2861-70
16107834 - Nature. 2005 Aug 18;436(7053):946-52
12441397 - Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8
15916940 - Curr Biol. 2005 May 24;15(10):R382-5
12198669 - Hepatology. 2002 Sep;36(3):743-54
21625589 - PLoS Pathog. 2011 May;7(5):e1002045
22101430 - Nature. 2012 Jan 19;481(7381):394-8
21481848 - Cell Immunol. 2011;269(2):104-14
10744077 - Lab Invest. 2000 Mar;80(3):415-22
17392433 - Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30
16108766 - J Viral Hepat. 2005 Sep;12(5):507-12
22929808 - Gastroenterology. 2012 Dec;143(6):1576-1585.e4
14647055 - Hepatology. 2003 Dec;38(6):1437-48
17919489 - Gastroenterology. 2007 Oct;133(4):1132-43
15122750 - Hepatology. 2004 May;39(5):1220-9
22160724 - Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21182-7
19891011 - World J Gastroenterol. 2009 Nov 7;15(41):5129-40
17082589 - J Immunol. 2006 Nov 15;177(10):6758-68
15661146 - Virology. 2005 Feb 5;332(1):130-44
21551190 - Gut. 2011 Nov;60(11):1563-71
7507411 - Cell. 1994 Jan 28;76(2):301-14
12663785 - J Virol. 2003 Apr;77(8):4781-93
14739110 - J Hepatol. 2004 Feb;40(2):341-52
20548953 - PLoS Pathog. 2010;6(6):e1000947
17039255 - J Clin Invest. 2006 Nov;116(11):3006-14
17433872 - Curr Opin Immunol. 2007 Jun;19(3):309-14
18471527 - Gastroenterology. 2008 May;134(5):1601-4
7475549 - Lancet. 1995 Oct 14;346(8981):1006-7
21739672 - Nat Immunol. 2011 Jun;12(6):492-9
18045940 - J Virol. 2008 Feb;82(4):1827-37
15239090 - Hepatology. 2004 Jul;40(1):87-97
19464986 - Immunity. 2009 May;30(5):636-45
18785267 - Cytometry A. 2008 Nov;73(11):975-83
10790425 - J Exp Med. 2000 May 1;191(9):1499-512
15611288 - J Exp Med. 2004 Dec 20;200(12):1593-604
19587449 - J Clin Invest. 2009 Jul;119(7):1745-54
19587053 - J Virol. 2009 Sep;83(18):9122-30
17067278 - Annu Rev Immunol. 2007;25:71-99
15962289 - Hepatology. 2005 Jul;42(1):104-12
12360469 - Gastroenterology. 2002 Oct;123(4):1070-83
15220475 - Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54
8698862 - J Clin Invest. 1996 Aug 1;98(3):706-14
19247441 - PLoS Pathog. 2009 Feb;5(2):e1000313
19229109 - J Clin Invest. 2009 Mar;119(3):551-64
21040725 - Gastroenterology. 2011 Feb;140(2):676-685.e1
15280806 - Ann Hepatol. 2002 Oct-Dec;1(4):192-5
8600540 - Science. 1996 Apr 5;272(5258):74-9
References_xml
SSID ssj0023352
Score 2.3917513
SecondaryResourceType review_article
Snippet Hepatitis C virus(HCV)infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma.HCV is a...
Hepatitis C virus (HCV) infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV is a...
SourceID pubmedcentral
crossref
pubmed
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3418
SubjectTerms Adaptive
Adaptive Immunity
Antibodies - immunology
Apoptosis
CD4-Positive T-Lymphocytes - cytology
CD8-Positive T-Lymphocytes - cytology
Cell Separation
Chemokines - metabolism
Epitopes - immunology
Flow Cytometry
Gene Deletion
Hepatitis
Hepatitis C - immunology
Humans
immune
Immunity, Cellular
Immunity, Humoral
Inflammation
Mutation
Phenotype
response
Topic Highlight
Title Adaptive immune response during hepatitis C virus infection
URI http://lib.cqvip.com/qk/84123X/201413/90888889504849524951484852.html
https://www.ncbi.nlm.nih.gov/pubmed/24707125
https://pubmed.ncbi.nlm.nih.gov/PMC3974509
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LSsQwFL04s9GNKL7GF1m4EUybtmnT4moYZ3CjCCq4K2najBWnjvPy973pC7u1u5IUysnjnEtO7gW4QkZRIko11ZHUlCshqeSJpJ6pUOMaAgvKIrbP4vEtvBubNDl-cxemNO2rJLeKz5lV5O-lt3I-U3bjE7OfHkbIoRyJzu5BD7VhE6LXUZa5RFQecTJBUZyI6mzSZFmxfz6m1sZlVu54Fu7eplafywWSrCmUvY3bTTH9RsLoUFTLS13P5B8SmuzBbq0eybD6y33YyooDuB2mcm52LZKbyx4ZWVS-14xUdxDJe2Zs06t8SUZkky_WS9JYsIpDeJ2MX0b3tK6JQBXnbEU100J4EpdhEGgVpjzJuNYuNvJIMTfRSjIdhKkjhI9vPqol3wuYl6JMc0LJvSPoF19FdgIkQCknE8PfKKNUGibSCVniSo3DmvlSDuCmhSSeV7kvYmOLwifyceVjbGUqV2NAxUPfHcB1g1rbGyMMA3yMwMcIfIzAxwb4ARxXaLY9m3EYgOjg3HYwabC7LTg7ynTY9Ww4_feXZ7CDMqjy44hz6K8W6-wCest0fVlOrV8GjdGW
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8JAEJ4IHvDiI77wuQcvJrYs7bZb4okgBCMQEzHx1my3XaiRirz8-862tJErvTW7PXS_3flmst_MANwho0jeCJWhGkIZTHJhCBYIw9YdaixNYG7axPaNDz68p7Yuk-PkuTCpaF8GsZl8TcwkHqfayulE1nKdWO2130IOZUh0tRLs4nmlNA_S13GWTiNKLzkpN9A94dntpK6zUvv9HJkri5px3TbRfutufRbjSLO6VXYFDU4y-kHK2CCpgpk2VZP_aKhzsOUPHML-2u8kzWz4CHai5Bgem6GYantHYp0mEpFZppiNSJa9SMaRFlwv4jlpkVU8W85JLt5KTuC90x62usa6m4IhGaMLQ1HFuS3wALuukl7IgogpZeEga0hqBUoKqlwvrHPu4JuDfpZju9QO0cGre4LZp1BOvpPoHIiLTqAINPOjAyZDLxB1jwaWULghIkeIKjwUS-lPs6oZvhZU4dNw0GZgVKZ7XmMoxjzHqsJ9vtrFbIxNNGA-AuYjYD4C5mvAqnCWoVDMzPGrAt_Ap5igC2hvjiAsaSHtNQwXW395C5XusN_ze8-Dl0vYQ2cqU_XwKygvZsvoGkrzcHmTbs8_psfnIw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwEB3RIgEXFrGV1QcuSCRxEydOxanqIhBQVQIkbpHjxG0QDaUbv884aSJ6hdwiTw7xs-fNyM8zAFfIKJI3ImWohlAGk1wYgoXCcHSHGlsTmJc1sX3mvTe_3dFlcspWX5loX4aJmX6MzDQZZtrK8UhahU7M6j-1kEMZEp01jpRVgXXcs9QuEvVlrqWvEmUHnZQbGKLw_IRS11qxvt8H5sKmZlJ3TPThumOfzThSrW6XvYlOJx18IW2sEFXJTqvKyV9U1N35x0_swvYy_iTN3GQP1uJ0H26bkRhrv0cSfV0kJpNcORuT_BYjGcZaeD1LpqRFFslkPiWFiCs9gNdu56V1Zyy7KhiSMTozFFWcOwI3sucp6UcsjJlSNg6yhqR2qKSgyvOjOucuvrkYb7mOR50IA726L5hzCNX0M42PgXgYDIpQRwAYiMnID0Xdp6EtFC6M2BWiBjfldAbjvHpGoIVV-DRc9B2Ynene15iSMd-1a3BdzHhpjTmKBi1A0AIELUDQAg1aDY5yJErLAsMa8BWMSgNdSHt1BKHJCmovoTj585eXsNFvd4PH-97DKWxhTJWLe_gZVGeTeXwOlWk0v8hW6A8RXumj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adaptive+immune+response+during+hepatitis+C+virus+infection&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Larrubia%2C+Juan+Ram%C3%B3n&rft.au=Moreno-Cubero%2C+Elia&rft.au=Lokhande%2C+Megha+Uttam&rft.au=Garc%C3%ADa-Garz%C3%B3n%2C+Silvia&rft.date=2014-04-07&rft.pub=Baishideng+Publishing+Group+Co.%2C+Limited&rft.issn=1007-9327&rft.volume=20&rft.issue=13&rft.spage=3418&rft.epage=3430&rft_id=info:doi/10.3748%2Fwjg.v20.i13.3418&rft_id=info%3Apmid%2F24707125&rft.externalDBID=PMC3974509
thumbnail_s http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg